Besides following our news, follow us on socials networks :
TransCure bioServices hires Adrien MOSSU – New Deputy Project Officer
Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.
Find more about how TransCure improves Inflammatory Bowel Diseases research with its humanized mouse model.
TransCure bioServices hires Benjamin TSCHUMI – New Deputy Project Officer
TransCure bioServices hires Olivier BAVEREY – Business Development Director
TransCure is proud to serve researchers in the field by providing suitable HIV mouse disease models.